Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-09-23 to 2022-10-17
Current total value of award: $1601.3
Description: 4558693695!ZOLADEX 3.6 MG IMPLANT SYRNS